TriVascular Technologies, Inc. 5/A
5/A · TriVascular Technologies, Inc. · Filed Feb 13, 2015
Insider Transaction Report
Form 5/AAmended
Kramer Michael R
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2013-11-29+32,043→ 32,043 totalExercise: $8.93From: 2014-11-01Exp: 2023-11-29→ Common Stock (32,043 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option are exercisable beginning on the one year anniversary of the vesting start date and in equal monthly installments thereafter over a four-year period.